Genetic variants in NUDT15 gene their clinical implications in cancer therapy
Yazun Jarrar1, Maria Ghishan2, Fatima Khirfan2
1Department of Basic Medical Sciences, Faculty of Medicine, Al-Balqa Applied University, Al-Salt, Jordan.
Abstract:
Individual variations in the response to thiopurine-based anticancer drugs are influenced by genetic and environmental factors, making it challenging to optimize dosing and minimize toxicity. Among the key genes involved, genetic variations in the nudix hydrolase 15 (NUDT15) gene affect on thiopurine metabolism, thus influencing drug efficacy and the risk of severe adverse effects, such as myelosuppression, These variations also contribute to inter-individual differences in drug tolerance and clinical outcomes. Despite the recognized impact of NUDT15 variations, there has been limited comprehensive exploration of these variants and their clinical significance in thiopurine therapy. This review provides a thorough analysis of NUDT15 genetic variants by synthesizing findings from prior clinical studies and employing in silico analyses to predict the functional effects of variants with uncertain significance. Comprehensive analysis of NUDT15 variants and their interactions with other metabolic pathways could offer valuable insights for advancing personalized medicine in cancer treatment. This review aims to establish a foundation for integrating NUDT15 genetic information into the clinical practice, reducing toxicity, and improved therapeutic outcomes in patients undergoing thiopurine-based chemotherapy.
Insights
Genetic variations in Nudix Hydrolase 15 (NUDT15) impact thiopurine drug metabolism and toxicity. Understanding these NUDT15 variants is crucial for personalized cancer therapy and improved patient outcomes.
Area of Science:
- Pharmacogenomics
- Oncology
- Molecular Biology
Background:
- Thiopurine anticancer drugs exhibit variable patient responses due to genetic and environmental factors.
- Genetic variations in Nudix Hydrolase 15 (NUDT15) significantly influence thiopurine metabolism, affecting drug efficacy and toxicity.
- Despite known impacts, a comprehensive analysis of NUDT15 variants in thiopurine therapy is lacking.
Purpose of the Study:
- To conduct a thorough analysis of NUDT15 genetic variants and their clinical significance in thiopurine therapy.
- To synthesize findings from existing clinical studies and predict functional effects of uncertain variants using in silico methods.
- To provide a foundation for integrating NUDT15 genetic information into clinical practice for personalized cancer treatment.
Main Methods:
- Literature review of clinical studies on NUDT15 variants and thiopurine therapy.
- In silico analysis to predict the functional impact of NUDT15 variants with uncertain significance.
- Synthesis of data to evaluate the role of NUDT15 in thiopurine metabolism and patient outcomes.
Main Results:
- NUDT15 genetic variations are key determinants of thiopurine drug response, influencing efficacy and toxicity.
- Specific NUDT15 variants are associated with increased risk of adverse events like myelosuppression.
- In silico predictions aid in understanding the functional consequences of previously uncharacterized NUDT15 variants.
Conclusions:
- Comprehensive analysis of NUDT15 variants is essential for optimizing thiopurine therapy.
- Integrating NUDT15 genetic testing into clinical practice can reduce toxicity and improve therapeutic outcomes.
- Further research into NUDT15 interactions with metabolic pathways will advance personalized medicine in oncology.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Genetic Variation
Genes exist in different versions called alleles,...
Single Nucleotide Polymorphisms-SNPs
Pleiotropy
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Incomplete Dominance
